Smith Stan's Form 4 filing
MAIA Biotechnology, Inc. (MAIA) · filed Feb 21, 2023
- Accession no.
- 0001127602-23-006047
- Filed
- Feb 21, 2023
- Trade date
- Feb 16-17, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $582.25. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith StanCIK 0001913199 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2023 | Common Stock | PPurchaseAcquired | +62 | $4.25 | +$263.5 | 514,171 | Indirect | |
| Feb 17, 2023 | Common Stock | PPurchaseAcquired | +75 | $4.25 | +$318.75 | 514,246 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.